Epstein-barr virus load in whole blood correlates with HIV surrogate markers and lymphoma: A French national cross-sectional study

Journal of Acquired Immune Deficiency Syndromes

Volumn 50, Issue 4, 2009, Pages 427-429

  Amiel, Corinne ^a   LeGoff, Jérôme ^b   Lescure, François Xavier ^a   Coste Burel, Marianne ^c   Deback, Claire ^d   Fafl Kremer, Samira ^e   Gueudin, Marie ^f   Lafon, Marie Edith ^g   Leruez Ville, Marianne ^h   Mengelle, Catherine ⁱ   Payan, Christopher ^j   Pillet, Sylvie ^k   Seigneurin, Jean Marie ^l  

^a HÔPITAL TENON   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Hôpital de Nantes   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Hôpital de Strasbourg   (France)

^f Hôpital de Rouen   (France)

^g Hôpital d'Enfants de Bordeaux   (France)

^h HÔPITAL NECKER ENFANTS MALADES   (France)

ⁱ Hopitaux de Toulouse   (France)

^j Hôpital de Brest   (France)

^k Hôpital de Saint Etienne   (France)

^l Universite de Grenoble   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DNA MARKER; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; B LYMPHOCYTE; BLOOD SAMPLING; EPSTEIN BARR VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LYMPHOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; B CELL LYMPHOMA; BLOOD; CROSS-SECTIONAL STUDY; ISOLATION AND PURIFICATION; VIROLOGY;

CROSS-SECTIONAL STUDIES; DNA, VIRAL; HERPESVIRUS 4, HUMAN; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; VIRAL LOAD;

EID: 64249138747     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31819a22ec     Document Type: Letter

References (15)

1. Dal Maso L, Franceschi S. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS. Lancet Oncol. 2003;4:110-119.
2. Besson C, Goubar A, Gabarre J, et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood. 2001;98:2339-2344.
3. Carbone A. AIDS-related non-Hodgkin's lymphomas: from pathology and molecular pathogenesis to treatment. Hum Pathol. 2002;33: 392-404.
4. Stevens SJ, Verschuuren EA, Prank I, et al. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood. 2001;97:1165.
5. Van Baarle D, Wolthers KC, Hovenkamp E, et al. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma. J Infect Dis. 2002; 186:405-409.
6. Stevens SJ, Blank BS, Smits PH, et al. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. AIDS. 2002;16:993-1001.
7. Stevens SJ, Smits PH, Verkuijlen AW, et al. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. AIDS. 2007;21:2141-2149.
8. Fan H, Kim SC, Chima CO, et al. Epstein-Barr viral load as a marker of lymphoma in AIDS patients. J Med Virol. 2005;75:59-69.
9. Fafi-Kremer S, Amiel C, Coste-Burel M, et al. Multicenter Quality Control Study for the Quantification of Epstein-Barr Virus DNA in the Whole Blood specimens. Presented at: 9th Annual ESCV Meeting; September 2006; Birmingham, United Kingdom. Abstract.
10. Legoff J, Amiel C, Calisonni O, et al. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection. J Clin Immunol. 2004;24:125-134.
11. Chene A, Donati D, Guerreiro-Cacais AO, et al. A molecular link between malaria and EpsteinBarr virus reactivation. PLoS Pathog. 2007;3:e80.
12. Bekker V, Scherpbier H, Beld M, et al. EpsteinBarr virus infects B and non-B lymphocytes in HIV-I-infected children and adolescents. J Infect Dis. 2006;194:1323-1330.
13. Piriou E, Van Dort K, Otto S, et al. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection. Clin Infect Dis. 2008;46:313-316.
14. Chan KC, Zhang J, Chan AT, et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res. 2003 ;63: 2028-2032.
15. Ryan JL, Fan H, Swinnen LJ, et al. EpsteinBarr virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies. Diagn Mol Pathol. 2004;13:61-68.